BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12794244)

  • 1. Immunohistochemical expression of TGF-beta1, p21WAF1, p53, Ki67, and angiogenesis in gastric carcinomas: a clinicopathologic study.
    Zolota V; Batistatou A; Tsamandas AC; Iliopoulos G; Scopa CD; Bonikos DS
    Int J Gastrointest Cancer; 2002; 32(2-3):83-9. PubMed ID: 12794244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of p53, p21WAF1, and TGF-beta1 in human ductal adenocarcinoma of the pancreas: TGF-beta1 protein expression predicts longer survival.
    Coppola D; Lu L; Fruehauf JP; Kyshtoobayeva A; Karl RC; Nicosia SV; Yeatman TJ
    Am J Clin Pathol; 1998 Jul; 110(1):16-23. PubMed ID: 9661918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
    Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
    J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma.
    Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Cancer; 1999 Oct; 86(8):1455-62. PubMed ID: 10526273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.
    Bennett WP; el-Deiry WS; Rush WL; Guinee DG; Freedman AN; Caporaso NE; Welsh JA; Jones RT; Borkowski A; Travis WD; Fleming MV; Trastek V; Pairolero PC; Tazelaar HD; Midthun D; Jett JR; Liotta LA; Harris CC
    Clin Cancer Res; 1998 Jun; 4(6):1499-506. PubMed ID: 9626468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
    Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
    J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of p21 WAF1/CIP1 protein in colorectal cancers: study of its relation to p53 mutation and Ki67 antigen expression].
    Chapusot C; Assem M; Martin L; Chalabreyssse L; Benhamiche AM; Lignier MA; Chauffert B; Teyssier JR; Faivre J; Piard F
    Pathol Biol (Paris); 2001 Mar; 49(2):115-23. PubMed ID: 11317955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastric cancer and tumor growth regulation. Study of cell proliferation markers and protein complex p53/p21WAF1/CIP1/mdm-2].
    Villaseca M; Araya JC; Roa I; Roa JC
    Rev Med Chil; 2000 Feb; 128(2):127-36. PubMed ID: 10962880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics.
    Culhaci N; Sagol O; Karademir S; Astarcioglu H; Astarcioglu I; Soyturk M; Oztop I; Obuz F
    BMC Cancer; 2005 Aug; 5():98. PubMed ID: 16086840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus.
    Heeren PA; Kloppenberg FW; Hollema H; Mulder NH; Nap RE; Plukker JT
    Anticancer Res; 2004; 24(4):2579-83. PubMed ID: 15330218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells.
    Kang SH; Bang YJ; Jong HS; Seo JY; Kim NK; Kim SJ
    Br J Cancer; 1999 Jun; 80(8):1144-9. PubMed ID: 10376964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of TGF beta (TGF-β), TGF beta receptor 1 (TGFBR1), and Ki67 in intestinal variant of gastric adenocarcinomas.
    Docea AO; Mitruţ P; Grigore D; Pirici D; Călina DC; Gofiţă E
    Rom J Morphol Embryol; 2012; 53(3 Suppl):683-92. PubMed ID: 23188426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
    Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ
    Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p21 expression is a prognostic factor in patients with p53-negative gastric cancer.
    Xiangming C; Hokita S; Natsugoe S; Tanabe G; Baba M; Takao S; Kuroshima K; Aikou T
    Cancer Lett; 2000 Feb; 148(2):181-8. PubMed ID: 10695995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclin dependent kinase inhibitor p21WAF1 alone and in combination with p27KIP1 shows prognostic value in gastric carcinoma.
    Jang SJ; Ahn MJ; Paik SS; Kong G; Keum JS; Park YW; Lee JD
    J Korean Med Sci; 1998 Aug; 13(4):369-76. PubMed ID: 9741540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.